Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)

China flag China · Delayed Price · Currency is CNY
8.50
-0.14 (-1.62%)
Feb 3, 2026, 3:00 PM CST
-22.37%
Market Cap7.98B -24.5%
Revenue (ttm)1.59B -48.8%
Net Income-332.62M
EPS-0.35
Shares Out939.26M
PE Ration/a
Forward PEn/a
Dividend0.15 (1.74%)
Ex-Dividend DateAug 20, 2025
Volume16,810,912
Average Volume19,401,693
Open8.63
Previous Close8.64
Day's Range8.43 - 8.72
52-Week Range8.10 - 13.48
Beta0.23
RSI38.80
Earnings DateApr 23, 2026

About SHA:603567

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China. [Read more]

Sector Healthcare
Founded 1996
Employees 2,349
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603567
Full Company Profile

Financial Performance

In 2024, SHA:603567's revenue was 2.70 billion, a decrease of -13.84% compared to the previous year's 3.14 billion. Earnings were 438.22 million, a decrease of -7.30%.

Financial Statements